Literature DB >> 3944932

Pulsed excimer laser angioplasty of human cadaveric arteries.

E M Farrell, L A Higginson, W S Nip, V M Walley, W J Keon.   

Abstract

Laser angioplasty has been limited by the lack of precise control of thermal and acoustic vascular injury. Pulsed excimer lasers, by contrast, have a capacity to affect target tissue without heat dispersion or damage to surrounding structures. The ablative properties of three excimer wavelengths, krypton fluoride (249 nm), xenon chloride (308 nm), and xenon fluoride (351 nm), were investigated with the use of fresh human cadaveric normal and atherosclerotic femoral arteries. Light and electron microscopy demonstrated clean cuts with histologically normal edges. There was no evidence of either thermal or acoustic damage with any of the wavelengths studied. The depth of ablation varied directly with the number of pulses and inversely with tissue density while the incision width remained constant. The excimer laser appears to offer significant advantages over its conventional counterparts for the ablation of atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944932     DOI: 10.1067/mva.1986.avs0030284

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

Review 1.  Endovascular surgery for peripheral arterial occlusive disease. A critical review.

Authors:  S S Ahn; D Eton; W S Moore
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

2.  Smooth excimer laser coronary angioplasty (SELCA) and conventional excimer laser angioplasty: Comparison of vascular injury and smooth muscle cell proliferation.

Authors:  M Oberhoff; A Baumbach; C Herdeg; S Hassenstein; D Y Xie; E Blessing; H Hanke; K K Haase; E Betz; K R Karsch
Journal:  Lasers Med Sci       Date:  1997-12       Impact factor: 3.161

3.  A comparison between argon-dye and excimer-dye laser for photodynamic effect in transplanted mouse tumor.

Authors:  T Okunaka; H Kato; C Konaka; H Sakai; H Kawabe; K Aizawa
Journal:  Jpn J Cancer Res       Date:  1992-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.